Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Epizyme Inc Appoints Jason P. Rhodes President


Wednesday, 3 Jul 2013 08:30am EDT 

Epizyme Inc announced that Jason P. Rhodes, Executive Vice President and Chief Financial Officer, has been named President of Epizyme. Mr. Rhodes, who was previously Executive Vice President and Chief Financial Officer, will continue to be Chief Financial Officer. 

Company Quote

26.53
-0.71 -2.61%
31 Oct 2014